169 related articles for article (PubMed ID: 28450698)
1. Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth.
Das A; Dhar K; Maity G; Sarkar S; Ghosh A; Haque I; Dhar G; Banerjee S; Banerjee SK
Sci Rep; 2017 Apr; 7(1):1220. PubMed ID: 28450698
[TBL] [Abstract][Full Text] [Related]
2. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.
Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK
BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids induce CCN5/WISP-2 expression and attenuate invasion in oestrogen receptor-negative human breast cancer cells.
Ferrand N; Stragier E; Redeuilh G; Sabbah M
Biochem J; 2012 Oct; 447(1):71-9. PubMed ID: 22765757
[TBL] [Abstract][Full Text] [Related]
4. WISP-2/CCN5 is involved as a novel signaling intermediate in phorbol ester-protein kinase Calpha-mediated breast tumor cell proliferation.
Sengupta K; Banerjee S; Dhar K; Saxena NK; Mehta S; Campbell DR; Banerjee SK
Biochemistry; 2006 Sep; 45(35):10698-709. PubMed ID: 16939222
[TBL] [Abstract][Full Text] [Related]
5. CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression.
Das A; Haque I; Ray P; Ghosh A; Dutta D; Quadir M; De A; Gunewardena S; Chatterjee I; Banerjee S; Weir S; Banerjee SK
Pharmacol Res Perspect; 2021 Apr; 9(2):e00753. PubMed ID: 33745223
[TBL] [Abstract][Full Text] [Related]
6. CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27(Kip1) via Skp2 and FOXO3a regulation.
Haque I; Banerjee S; De A; Maity G; Sarkar S; Majumdar M; Jha SS; McGragor D; Banerjee SK
Oncogene; 2015 Jun; 34(24):3152-63. PubMed ID: 25132260
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells.
Dhar K; Banerjee S; Dhar G; Sengupta K; Banerjee SK
Cancer Res; 2007 Feb; 67(4):1520-6. PubMed ID: 17308090
[TBL] [Abstract][Full Text] [Related]
8. Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells.
Fritah A; Saucier C; De Wever O; Bracke M; Bièche I; Lidereau R; Gespach C; Drouot S; Redeuilh G; Sabbah M
Mol Cell Biol; 2008 Feb; 28(3):1114-23. PubMed ID: 18070926
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
[TBL] [Abstract][Full Text] [Related]
10. Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2.
Dhar G; Banerjee S; Dhar K; Tawfik O; Mayo MS; Vanveldhuizen PJ; Banerjee SK
Cancer Res; 2008 Jun; 68(12):4580-7. PubMed ID: 18559502
[TBL] [Abstract][Full Text] [Related]
11. Identification of a GαGβγ, AKT and PKCα signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition.
Ouelaa-Benslama R; De Wever O; Hendrix A; Sabbah M; Lambein K; Land D; Prévost G; Bracke M; Hung MC; Larsen AK; Emami S; Gespach C
Int J Oncol; 2012 Jul; 41(1):189-200. PubMed ID: 22552300
[TBL] [Abstract][Full Text] [Related]
12. Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1α-TWIST signaling networks in human breast cancer cells.
Haque I; Banerjee S; Mehta S; De A; Majumder M; Mayo MS; Kambhampati S; Campbell DR; Banerjee SK
J Biol Chem; 2011 Dec; 286(50):43475-85. PubMed ID: 22020939
[TBL] [Abstract][Full Text] [Related]
13. The matricellular protein CCN6 (WISP3) decreases Notch1 and suppresses breast cancer initiating cells.
Huang W; Martin EE; Burman B; Gonzalez ME; Kleer CG
Oncotarget; 2016 May; 7(18):25180-93. PubMed ID: 26933820
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens.
Fritah A; Redeuilh G; Sabbah M
J Endocrinol; 2006 Dec; 191(3):613-24. PubMed ID: 17170219
[TBL] [Abstract][Full Text] [Related]
15. CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen.
Sarkar S; Ghosh A; Banerjee S; Maity G; Das A; Larson MA; Gupta V; Haque I; Tawfik O; Banerjee SK
Oncogenesis; 2017 May; 6(5):e340. PubMed ID: 28530705
[TBL] [Abstract][Full Text] [Related]
16. Loss of WISP2/CCN5 in estrogen-dependent MCF7 human breast cancer cells promotes a stem-like cell phenotype.
Ferrand N; Gnanapragasam A; Dorothee G; Redeuilh G; Larsen AK; Sabbah M
PLoS One; 2014; 9(2):e87878. PubMed ID: 24498388
[TBL] [Abstract][Full Text] [Related]
17. Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition.
Dhar G; Mehta S; Banerjee S; Gardner A; McCarty BM; Mathur SC; Campbell DR; Kambhampati S; Banerjee SK
Cancer Lett; 2007 Aug; 254(1):63-70. PubMed ID: 17383817
[TBL] [Abstract][Full Text] [Related]
18. CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells.
Banerjee S; Dhar G; Haque I; Kambhampati S; Mehta S; Sengupta K; Tawfik O; Phillips TA; Banerjee SK
Cancer Res; 2008 Sep; 68(18):7606-12. PubMed ID: 18794149
[TBL] [Abstract][Full Text] [Related]
19. Wnt1 inducible signalling pathway protein-2 (WISP‑2/CCN5): roles and regulation in human cancers (review).
Ji J; Jia S; Ji K; Jiang WG
Oncol Rep; 2014 Feb; 31(2):533-9. PubMed ID: 24337439
[TBL] [Abstract][Full Text] [Related]
20. WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways.
Ji J; Jia S; Jia Y; Ji K; Hargest R; Jiang WG
Br J Cancer; 2015 Sep; 113(6):921-33. PubMed ID: 26291058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
